Return to search results.
Complete title: A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine
|Research Study Number||20101327|
|Principal Investigator||Veena Shankaran|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Colon Cancer; Gastrointestinal Cancer; Rectal Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.